Abstract
Objective
To determine whether size of the piriformis muscle, as characterized by either the coronal width or a segmented volume, correlates with outcomes after CT-guided injections.
Materials and methods
A consecutive series of 81 patients with piriformis syndrome received CT-guided injections of the sciatic nerve and piriformis muscle. Volume and thickness measurements of the piriformis were taken from T1W and T2W pre-injection images by two readers. A logistic regression was used to test volume and size effect on first injection response. A cox proportional hazards model was used to evaluate pain-free survival. Identical analyses were performed to test the effects of muscle mass abnormality, nerve abnormality, body mass index, and presence of a split sciatic nerve.
Results
There were 15/94 negative responses, 31/94 possible positive responses, and 48/94 positive responses to CT-guided injection. The average pain-free survival time was 38.91 ± 64.43 days. There was no significant correlation of first injection responses with muscle thickness or volume. There was no significant correlation in pain-free survival for muscle thickness or volume. There was no significant correlation in first injection response or pain-free survival with body mass index, muscle abnormalities, nerve abnormalities, or split sciatic nerves. The intraclass correlation was excellent between the two readers for both muscle volume (0.95–0.98) and thickness (0.92–0.97).
Conclusion
Piriformis muscle volume or thickness did not significantly correlate with post-injection outcome (first injection response and pain-free survival). Thus, if the patient has clinical symptoms of piriformis syndrome, the size of muscle should not determine whether injection is advisable.
Similar content being viewed by others
Abbreviations
- MRN:
-
Magnetic Resonance Neurography
- T2W:
-
T2-Weighted
References
Chang A, Varacallo M. Piriformis injection statpearls. Treasure Island: StatPearls Publishing LLC; 2018.
Chen CK, J Nizar A. Prevalence of piriformis syndrome in chronic low back pain patients. A clinical diagnosis with modified fair test, 2012.
Singh S, Deshmukh P, Ungratwar A, Subramanyam A, Kamath R. Does resilience affect illness perception and well-being in the elderly? J Med Soc. 2013;27(2):94–9.
Boyajian-O’Neill LA, McClain RL, Coleman MK, Thomas PP. Diagnosis and management of piriformis syndrome: An osteopathic approach. J Am Osteopathic Assoc. 2008;108(11):657–64.
Hopayian K, Song F, Riera R, Sambandan S. The clinical features of the piriformis syndrome: a systematic review. Euro Spine J. 2010;19(12):2095–109.
Filler AG. Piriformis and related entrapment syndromes: diagnosis & management. Neurosurg Clin N Am. 2008;19(4):609–22.
Hernando MF, Cerezal L, Perez-Carro L, Abascal F, Canga A. Deep gluteal syndrome: anatomy, imaging, and management of sciatic nerve entrapments in the subgluteal space. Skeletal Radiol. 2015;44(7):919–34.
Fanucci E, Masala S, Sodani G, Varrucciu V, Romagnoli A, Squillaci E, et al. CT-guided injection of botulinic toxin for percutaneous therapy of piriformis muscle syndrome with preliminary MRI results about denervative process. Eur Radiol. 2001;11(12):2543–8.
Cassidy L, Walters A, Bubb K, Shoja MM, Tubbs RS, Loukas M. Piriformis syndrome: implications of anatomical variations, diagnostic techniques, and treatment options. Surg Radiol Anat. 2012;34(6):479–86.
Filler AG, Haynes J, Jordan SE, Prager J, Villablanca JP, Farahani K, et al. Sciatica of nondisc origin and piriformis syndrome: diagnosis by magnetic resonance neurography and interventional magnetic resonance imaging with outcome study of resulting treatment. J Neurosurg Spine. 2005;2(2):99–115.
Chhabra A, Chalian M, Soldatos T, Andreisek G, Faridian-Aragh N, Williams E, et al. 3-T high-resolution MR neurography of sciatic neuropathy. Am J Roentgenol. 2012;198(4):W357–64.
Yang HE, Park JH, Kim S. Usefulness of magnetic resonance neurography for diagnosis of piriformis muscle syndrome and verification of the effect after botulinum toxin type a injection: two cases. Medicine. 2015;94(38):e1504–e1504.
Jankovic D, Peng P, van Zundert A. Brief review: Piriformis syndrome: etiology, diagnosis, and management. Canad J Anesthesia/Journal canadien d’anesthésie. 2013;60(10):1003–12.
Jabbari B. Botulinum toxin treatment of piriformis syndrome. In: Jabbari B, editor. Botulinum toxin treatment of pain disorders. New York: Springer; 2015. p. 99–108.
Fishman LM, Anderson C, Rosner B. BOTOX and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil. 2002;81(12):936–42.
Kirschner JS, Foye PM, Cole JL. Piriformis syndrome, diagnosis and treatment. Muscle Nerve. 2009;40(1):10–8.
Fishman LM, Konnoth C, Rozner B. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study. Am J Phys Med Rehab. 2004;83(1):42–50.
Yoon SJ, Ho J, Kang HY, Lee SH, Kim KI, Shin WG, et al. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome. Pharmacotherapy. 2007;27(5):657–65.
Al-Al-Shaikh M, Michel F, Parratte B, Kastler B, Vidal C, Aubry S. An MRI evaluation of changes in piriformis muscle morphology induced by botulinum toxin injections in the treatment of piriformis syndrome. Diagn Interv Imaging. 2015;96(1):37–43.
Park CH, Lee SH, Lee SC, Park HS. Piriformis muscle: clinical anatomy with computed tomography in korean population. Korean J Pain. 2011;24(2):87–92.
Skorupska E, Keczmer P, Łochowski RM, Tomal P, Rychlik M, Samborski W. Reliability of MR-based volumetric 3-D analysis of pelvic muscles among subjects with low back with leg pain and healthy volunteers. PLOS ONE. 2016;11(7):e0159587.
Wadhwa V, Scott KM, Rozen S, Starr AJ, Chhabra A. CT-guided perineural injections for chronic pelvic pain. Radiographics. 2016;36(5):1408–25.
Misirlioglu TO, Akgun K, Palamar D, Erden MG, Erbilir T. Piriformis syndrome: comparison of the effectiveness of local anesthetic and corticosteroid injections: a double-blinded, randomized controlled study. Pain Phys. 2015;18(2):163–71.
Brodsky MA, Swope DM, Grimes D. Diffusion of botulinum toxins. Tremor Other Hyperkinet Mov. 2012;2:02.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Approval from the Institutional Review Board was obtained, and HIPAA requirements were followed. Informed consent was not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hlis, R., Yan, K., Xi, Y. et al. Piriformis syndrome: muscle thickness or volume does not correlate with response to CT-guided injection. Skeletal Radiol 51, 1407–1414 (2022). https://doi.org/10.1007/s00256-021-03970-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-021-03970-x